PsiOxus Therapeutics Limited Completes Patient Enrollment for Phase II Wasting Disease Therapeutic MT-102
3/4/2013 10:30:04 AM
More...
|
DTRA Awards $3.3 Million Contract to PsiOxus Therapeutics Limited to Develop Biodefence Vaccine Adjuvants
1/16/2013 9:08:14 AM
More...
|
IXICO and PsiOxus Therapeutics Limited Win Significant Funding From Government-Backed Biomedical Catalyst
11/5/2012 3:25:16 PM
More...
|
UK Government Awards £1.7 Million Grant to PsiOxus Therapeutics Limited for Second Phase I/II Clinical Trial of Cancer Vaccine
11/5/2012 10:58:02 AM
More...
|
PsiOxus Therapeutics Limited Launches Phase I/II Clinical Trial of Oncolytic Vaccine With Dosing of Patient With Metastatic Cancer
9/26/2012 8:38:59 AM
More...
|
Imperial Innovations Leads $34 Million Funding Round for PsiOxus Therapeutics Limited
7/9/2012 6:53:45 AM
More...
|
PsiOxus Therapeutics Limited Moves into New Facilities on Milton Park to Accommodate Expansion
4/24/2012 8:59:18 AM
More...
|
PsiOxus Therapeutics Limited Initiates Phase II Clinical Study of Wasting Disease Therapeutic MT-102
3/17/2011 8:40:10 AM
More...
|